Proteomic age acceleration

Biomarker

1 paper3 findings

In a human preprint study, proteomic age acceleration is associated with mortality, while longitudinal within-individual analyses link it to impaired kidney function and dyslipidaemia.

  • Humans1

Associations

3

Mortality

upin humans1

1 study
  1. Proteomic age acceleration is associated with mortality in humans.

    Humansn = 4,100

    Blood protein clock tracks shifts in health risks over time

    bioRxiv6 Oct 2026Preprint

Impaired kidney function

upin humans1

1 study
  1. Impaired kidney function is associated with proteomic age acceleration in humans.

    HumansWithin-individual longitudinal changesn = 4,100

    Blood protein clock tracks shifts in health risks over time

    bioRxiv6 Oct 2026Preprint

Dyslipidemia

upin humans1

1 study
  1. Dyslipidemia is associated with proteomic age acceleration in humans.

    HumansWithin-individual longitudinal changesn = 4,100

    Blood protein clock tracks shifts in health risks over time

    bioRxiv6 Oct 2026Preprint

More on Dyslipidemia

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 13 in 12 months
bioRxiv

Blood protein clock tracks shifts in health risks over time

In an observational study of 4,100 people, accelerated blood protein aging tracked worsening kidney function, blood lipid imbalances, and a higher risk of death.In an observational study of 4,100 people, accelerated blood protein aging tracked worsening kidney function, blood lipid imbalances, and a higher risk of death.

Preprint: cohort study of 4,100 peopleBiomarkers